摘要
“营养”食品衍生产品主要用于保健和预防疾病的作用。近年来,许多努力都旨在评估和安全保健品的功效,但这些因素都难以解决由于复杂的化学成分和多模式行为。因此,营养成分的研究对药物化学领域的一些挑战,其中一些是相关的提取和化学表征,一些在体外和体内活性评价和一些与这些天然的混合物与器官和微生物之间的相互作用的生物利用度。此外,由于其药用和食品的性质,这些保健品也可以被视为一个有价值的新的先导化合物的来源”,创造机会发现治疗药物新课。本文提供了有关这些主题的信息,表明综合药物化学的研究是在保健品领域应对新的挑战。
关键词: 保健食品、天然产物、代谢组学、抗氧化剂、黄酮类化合物、微生物。
Current Medicinal Chemistry
Title:Nutraceuticals, A New Challenge for Medicinal Chemistry
Volume: 23 Issue: 28
Author(s): Stefania Sut, Valeria Baldan, Marta Faggian, Gregorio Peron, Stefano Dall`Acqua
Affiliation:
关键词: 保健食品、天然产物、代谢组学、抗氧化剂、黄酮类化合物、微生物。
摘要: “Nutraceuticals” are food-derived products largely used for their presumed healthpromoting or disease-preventing effects. In the recent years, many efforts have been aimed at assessing nutraceutical efficacy and safety, but these factors are difficult to address because of the complex chemical compositions and multiple mode of actions. Thus, the study of nutraceutical ingredients poses several challenges for the medicinal chemistry field, some of which are related to extraction and chemical characterization, some to in vitro and in vivo bioactivity evaluation, and some to the bioavailability and interaction of these natural mixtures with organs and microbiota. Furthermore, because of their nature as medicinal and food products, these nutraceuticals can also be considered as a valuable source of new “lead compounds”, creating the opportunity to discover new classes of therapeutic agents. This review provides information on these themes, showing the new challenges that comprehensive medicinal chemistry research is called to answer in the field of nutraceuticals.
Export Options
About this article
Cite this article as:
Stefania Sut, Valeria Baldan, Marta Faggian, Gregorio Peron, Stefano Dall`Acqua , Nutraceuticals, A New Challenge for Medicinal Chemistry, Current Medicinal Chemistry 2016; 23 (28) . https://dx.doi.org/10.2174/0929867323666160615104837
DOI https://dx.doi.org/10.2174/0929867323666160615104837 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Clinical Difference between Gabapentin and Pregabalin: Data from a Pilot Comparative Trial
Reviews on Recent Clinical Trials Combating Mosquito-Borne Lymphatic Filariasis with Genomics Technologies: Enabling Novel Drug Discovery for Neglected Tropical Diseases
Current Pharmacogenomics and Personalized Medicine Synthesis, Antibacterial and Antifungal Activities of 3-Amino-5- methyl[1,1'-biphenyl]-2,4-dicarbonitrile Derivatives
Letters in Drug Design & Discovery Renin-Angiotensin System in Central Nervous System Diseases and its Interaction with COVID-19
Current Medicinal Chemistry Bioactive N-Phenylimidazole Derivatives
Current Chemical Biology Basis for the Application of Analytical Models of the Bloch NMR Flow Equations for Functional Magnetic Resonance Imaging (fMRI): A Review
Recent Patents on Medical Imaging Therapeutic Benefits of <i>Piper nigrum</i>: A Review
Current Bioactive Compounds Role of Noradrenergic and Orexinergic Neurons in General Anesthesia
Current Neuropharmacology Functional Neuroimaging in Memory and Memory Disturbances
Current Medical Imaging Neonatal Atlas Templates for the Study of Brain Development Using Magnetic Resonance Images
Current Medical Imaging PET Studies on P-Glycoprotein Function in the Blood-Brain Barrier: How it Affects Uptake and Binding of Drugs within the CNS
Current Pharmaceutical Design FMRI of the Emotions: Towards an Improved Understanding of Amygdala Function
Current Medical Imaging Human Disease and Drug Pharmacology, Complex as Real Life
Current Medicinal Chemistry Molecular Regulation and Pharmacology of Pacemaker Channels
Current Pharmaceutical Design The Hypothalamus and Obesity
Recent Patents on CNS Drug Discovery (Discontinued) HMG-CoA Reductase Inhibitors (Statins) and their Drug Interactions Involving CYP Enzymes, P-glycoprotein and OATP Transporters-An Overview
Current Drug Metabolism Cytochrome P450 in Neurological Disease
Current Drug Metabolism Nutraceuticals in Psychiatric Practice
Recent Patents on CNS Drug Discovery (Discontinued) Benzopentathiepine Derivative, 8-(Trifluoromethyl)-1,2,3,4,5-Benzopentathiepin- 6-Amine Hydrochloride (TC-2153), as a Promising Antidepressant of New Generation
Letters in Drug Design & Discovery Editorial [Hot Topic: New Mechanisms of Neuronal Injury and Neuroprotection (Guest Editor: Weihai Ying)]
Current Drug Targets